IMPROVE-IT : Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

IMPROVE-IT : Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Ezetimibe should be considered as add-on therapy for secondary prevention after a serious CV event or procedure. The goal LDL-c threshold should be <70mg/dL in this setting. (AHA lipid guidelines 2018)

Infographic

Reference

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med. 2015 Jun 18;372(25):2387-97.

>